- NCT00006455
Combination Chemotherapy in Treating Children With Anaplastic Large Cell Lymphoma (ALCL 99)
Phase 3Completed - NCT00005973
BMS-214662 in Treating Patients With Solid Tumors
Phase 1Completed - NCT00046826
Docetaxel, Estramustine, and Thalidomide in Treating Patients With Prostate Cancer Previously Treated With Hormone Therapy
Phase 2Completed - NCT00005967
Tipifarnib in Treating Patients With Advanced Hematologic Cancer
Phase 1Completed - NCT00005966
Interferon Alfa-2b With or Without Thalidomide in Treating Patients With Metastatic or Unresectable Kidney Cancer
Phase 3Completed - NCT00046865
Acupressure in Treating Nausea in Women Receiving Combination Chemotherapy for Breast Cancer
Phase 3Completed - NCT00005961
O6-benzylguanine and Carmustine in Treating Patients With Unresectable Locally Recurrent or Metastatic Melanoma
Phase 2Completed - NCT00019565
PET and/or MRI Scans in Assessing Tumor Response in Patients Receiving Antiangiogenesis Therapy
Phase 1Completed - NCT00005957
Radiation Therapy in Treating Women Who Have Undergone Surgery for Early-Stage Invasive Breast Cancer
Not ApplicableCompleted - NCT00005955
Temozolomide Followed by Radiation Therapy in Treating Children With Newly Diagnosed Malignant CNS Tumors
Phase 2Completed - NCT00005954
Temozolomide in Treating Patients With Brain Metastases
Phase 2Completed - NCT00046904
Etanercept in Treating Cancer-Related Cachexia and Anorexia in Patients With Advanced Cancer
Phase 3Completed - NCT00005951
Irinotecan Plus Temozolomide in Treating Patients With Recurrent Primary Malignant Glioma
Phase 1Completed - NCT00046917
Combination Chemotherapy in Treating Patients With Advanced Solid Tumors
Phase 1Completed - NCT00046943
Atrasentan in Treating Patients With Prostate Cancer
Phase 3Completed - NCT00047008
Chemotherapy and Radiation Therapy With or Without Surgery in Treating Patients With Head and Neck Cancer
Phase 3Completed - NCT00047034
E7389 in Treating Patients With Advanced Solid Tumors
Phase 1Completed - NCT00047047
Tanespimycin, Gemcitabine Hydrochloride, and Cisplatin in Treating Patients With Advanced Solid Tumors
Phase 1Completed - NCT00003216
Fluorouracil, Gemcitabine, and Radiation Therapy in Treating Patients With Cancer of the Pancreas
Phase 3Completed - NCT00047060
Stem Cell Transplant Therapy With Campath-1H for Treating Advanced Mycosis Fungoides and Sezary Syndrome
Phase 1Completed - NCT00047190
Tipifarnib in Treating Patients With Myelofibrosis and Myeloid Metaplasia
Phase 2Completed - NCT00047203
Flavopiridol in Treating Patients With Relapsed or Refractory Multiple Myeloma
Phase 2Completed - NCT00047216
Tipifarnib in Treating Patients With Recurrent Bladder Cancer
Phase 2Completed - NCT00047229
Oblimersen and Doxorubicin in Treating Patients With Advanced Hepatocellular Carcinoma (Liver Cancer)
Phase 2Completed - NCT00047242
UCN-01 and Irinotecan in Treating Patients With Advanced Solid Tumors
Phase 1Completed - NCT00047255
Docetaxel and Trastuzumab With or Without Carboplatin in Treating Women With HER2-Positive Breast Cancer
Phase 3Completed - NCT00047281
Thalidomide, Celecoxib, and Combination Chemotherapy in Treating Patients With Relapsed or Refractory Malignant Glioma
Phase 2Completed - NCT00047307
Flavopiridol Plus Radiation Therapy Followed By Gemcitabine Hydrochloride in Treating Patients With Locally Advanced, Unresectable Pancreatic Cancer
Phase 1Completed - NCT00047333
Erlotinib in Treating Patients With Liver Cancer That Cannot be Surgically Removed
Phase 2Terminated - NCT00047346
Erlotinib in Treating Patients With Unresectable Liver Cancer and Liver Dysfunction
Phase 1Completed - NCT00047385
National Lung Screening Trial (NLST) Screening
Phase 3Completed - NCT00005878
Celecoxib to Prevent Cancer in Patients With Barrett's Esophagus
Phase 2Completed - NCT00023998
Chemotherapy With or Without Trastuzumab in Treating Patients With Metastatic Osteosarcoma
Phase 2Completed - NCT00031577
Paclitaxel Plus Radiation Therapy in Treating Children With Newly Diagnosed Brain Stem Glioma
Phase 1Terminated - NCT00042809
Erlotinib, Trastuzumab, and Paclitaxel in Treating Patients With Advanced Solid Tumors
Phase 1Completed - NCT00005867
Combination Chemotherapy in Treating Patients With Aggressive Non-Hodgkin's Lymphoma
Phase 3Completed - NCT00005859
Tipifarnib in Treating Patients With Recurrent or Progressive Malignant Glioma
Phase 1Completed - NCT00005858
LMB-9 Immunotoxin in Treating Patients With Advanced Colon, Breast, Non-small Cell Lung, Bladder, Pancreatic, or Ovarian Cancer
Phase 1Completed - NCT00005855
Efaproxiral Plus Carmustine in Treating Patients With Progressive or Recurrent Malignant Glioma
Phase 1Completed - NCT00014092
Chemotherapy Followed by Biological Therapy in Treating Patients With Stage IV Melanoma That Cannot be Treated With Surgery
Phase 2Completed - NCT00048958
Cytogenetic Studies in Acute Leukemia and Multiple Myeloma
Active Not Recruiting - NCT00048971
Genetic Trial to Study Diarrhea in Patients With Stage III Colon Cancer Who Are Receiving Chemotherapy
Completed - NCT00048984
Diagnostic Study of Tumor Characteristics in Patients With Ewing's Sarcoma
Completed - NCT00045227
Vaccine Therapy With or Without Docetaxel in Treating Patients With Metastatic Prostate Cancer
Phase 2Completed - NCT00049023
Radiolabeled Octreotide in Treating Children With Advanced or Refractory Solid Tumors
Phase 1Completed - NCT00049062
Anastrozole and ZD 1839 in Treating Postmenopausal Women With Metastatic Breast Cancer
Phase 2Completed - NCT00049075
Fludarabine in Treating Patients With Chronic Lymphocytic Leukemia
Phase 2Completed - NCT00049127
Imatinib Mesylate in Treating Patients With Recurrent Brain Tumor
Phase 1Completed - NCT00049166
Erlotinib and Radiation Therapy With or Without Cisplatin in Treating Patients With Mouth or Throat Cancer
Phase 1Completed - NCT00049179
S0117 Gemtuzumab Ozogamicin Plus Cytarabine in Treating Patients With Relapsed Acute Myeloid Leukemia
Phase 2Completed - NCT00049192
Oblimersen and Imatinib Mesylate in Treating Patients With Chronic Myelogenous Leukemia
Phase 2Completed - NCT00049218
Chemotherapy Followed By Vaccine Therapy in Treating Patients With Extensive-Stage Small Cell Lung Cancer
Phase 1Completed - NCT00049257
Paclitaxel and Carboplatin in Treating Patients With Metastatic Prostate Cancer That Has Not Responded to Hormone Therapy
Phase 2Completed - NCT00049296
Thalidomide and Docetaxel in Treating Patients With Advanced Cancer
Phase 1Completed - NCT00049374
Oblimersen, Thalidomide, and Dexamethasone in Treating Patients With Relapsed or Refractory Multiple Myeloma
Phase 2Completed - NCT00049400
S0355 Ixabepilone in Treating Patients With Advanced Solid Tumors or Lymphomas and Liver Dysfunction
Phase 1Completed - NCT00049452
Zoledronate in Preventing Bone Loss in Premenopausal Women Receiving Chemotherapy After Surgery For Early Stage Breast Cancer
Phase 3Completed - NCT00005851
Low-Dose Total-Body Irradiation and Fludarabine Phosphate Followed By Donor Peripheral Blood Stem Cell Transplant in Treating Patients With Stage IV Kidney Cancer
Phase 1Completed - NCT00005850
Combination Chemotherapy Plus Fluoxetine in Treating Patients With Advanced or Recurrent Non-Small Cell Lung Cancer
Phase 2Completed - NCT00005847
Chemotherapy With or Without Biological Therapy in Treating Patients With Metastatic Prostate Cancer That Has Not Responded to Hormone Therapy
Phase 2Completed - NCT00049465
Standard Follow-up Compared With Extended Follow-up in Treating Patients Who Have Undergone Stem Cell Transplantation for Cancer
Not ApplicableCompleted - NCT00016887
Chemotherapy Followed by Radiation Therapy and Peripheral Stem Cell Transplant Compared With Chemotherapy Plus Interferon Alfa in Treating Patients With Stage III or Stage IV Mantle Cell Lymphoma
Phase 3Unknown - NCT00002941
Combination Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Children With Recurrent or Refractory Hodgkin's or Non-Hodgkin's Lymphoma
Phase 2Completed - NCT00049582
Decitabine in Treating Patients With Myelodysplastic Syndromes or Acute Myeloid Leukemia
Phase 1Terminated - NCT00049608
Gemcitabine Combined With Mistletoe in Treating Patients With Advanced Solid Tumors
Phase 1Terminated - NCT00049634
Donor Peripheral Stem Cell Transplant in Treating Patients With Myelodysplastic Syndrome, Acute Myeloid Leukemia, or Myeloproliferative Disorder
Phase 1Completed - NCT00049673
Thalidomide and Prednisone After Autologous Stem Cell Transplantation Multiple Myeloma
Phase 3Completed - NCT00049686
VNP40101M in Treating Patients With Relapsed or Refractory Leukemia or Myelodysplastic Syndrome
Phase 1Completed - NCT00049699
VNP40101M in Treating Patients With Advanced or Metastatic Cancer
Phase 1Completed - NCT00049712
Monoclonal Antibody Therapy in Treating Patients With Refractory Advanced Solid Tumors or Lymphoma
Phase 1Completed - NCT00020358
Vaccine Therapy in Treating Patients With Melanoma
Phase 2Completed - NCT00052780
Temozolomide and O6-Benzylguanine in Treating Children With Recurrent Brain Tumors
Phase 1Completed - NCT00002569
Radiation Therapy With or Without Chemotherapy in Treating Patients With Anaplastic Oligodendroglioma
Phase 3Completed - NCT00005825
Combination Chemotherapy in Treating Patients With Stage IIIB or Stage IV Non-small Cell Lung Cancer
Phase 2Unknown - NCT00005823
Intensive Compared With Nonintensive Chemotherapy in Treating Older Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome
Phase 3Completed - NCT00005821
Sentinel Lymph Node Biopsy to Assess Axillary Lymph Nodes in Women With Stage I or Stage II Breast Cancer
Phase 2Unknown - NCT00003389
Combination Chemotherapy With or Without Radiation Therapy in Treating Patients With Hodgkin's Lymphoma
Phase 3Completed - NCT00014326
Involved-Field Radiation Therapy in Treating Patients With Previously Untreated Stage I or Stage II Low-Grade Non-Hodgkin's Lymphoma
Phase 3Terminated - NCT00002615
Surgery With or Without Combination Chemotherapy in Treating Patients With Stomach Cancer
Phase 3Completed - NCT00003994
Combination Chemotherapy With or Without Amifostine in Treating Young Patients With Liver Cancer
Phase 3Completed - NCT00005819
Combination Chemotherapy in Treating Patients With Advanced Solid Tumors
Phase 1Completed - NCT00005817
Rebeccamycin Analogue in Treating Women With Stage IIIB or Stage IV Breast Cancer
Phase 2Completed - NCT00032149
Combination Chemotherapy Plus Filgrastim in Treating Patients With HIV-Related Non-Hodgkin's Lymphoma
Phase 1Unknown - NCT00005815
Temozolomide and Thalidomide in Treating Patients With Stage III or Stage IV Melanoma
Phase 1Completed - NCT00005812
Temozolomide in Treating Patients With Leptomeningeal Metastases From a Solid Tumor or Lymphoma
Phase 2Terminated - NCT00005811
Topotecan Hydrochloride in Treating Children With Meningeal Cancer That Has Not Responded to Previous Treatment
Phase 2Completed - NCT00005807
Treating Patients With Advanced Solid Tumors, Breast Cancer or Recurrent Ovarian Cancer
Phase 1Completed - NCT00011921
Chemotherapy Followed by Peripheral Stem Cell or Bone Marrow Transplant Compared With Chemotherapy Alone in Treating Patients With Small Cell Lung Cancer
Phase 3Unknown - NCT00005803
Autologous Stem Cell Transplant Followed by Donor Stem Cell Transplant in Treating Patients With Relapsed or Refractory Lymphoma
Phase 1Completed - NCT00004088
Combination Chemo, Peripheral Stem Cell Transplant, Biological Therapy, Pamidronate and Thalidomide for Multiple Myeloma
Phase 2Completed - NCT00019604
Radiofrequency Ablation in Treating Patients With Unresectable Primary or Metastatic Liver Cancer
Phase 2Terminated - NCT00005797
Bone Marrow Transplant in Treating Patients With Hematologic Cancers
Phase 2Completed - NCT00039273
Monoclonal Antibody Therapy in Treating Patients With Metastatic Colorectal Cancer
Phase 2Completed - NCT00048997
Radiation Therapy in Preventing Central Nervous System (CNS) Metastases in Patients With Non-Small Cell Lung Cancer
Phase 3Completed - NCT00005786
Arsenic Trioxide in Treating Patients With Relapsed or Refractory Lymphoma or Leukemia
Not ApplicableTerminated - NCT00005822
SU5416 and Doxorubicin in Treating Patients With Stage IIIB or Stage IV Inflammatory Breast Cancer
Phase 1Completed - NCT00002598
Combination Chemotherapy and Interferon Alfa in Treating Patients With Chronic Myelogenous Leukemia
Phase 2Completed - NCT00002700
Chemotherapy With or Without Bone Marrow Transplantation in Treating Patients With Acute Lymphoblastic Leukemia
Phase 3Completed - NCT00025233
Bevacizumab in Treating Patients With Persistent or Recurrent Cancer of the Cervix
Phase 2Completed - NCT00015951
Bevacizumab, Cytarabine, and Mitoxantrone on Treating Patients With Hematologic Cancers
Phase 2Completed